VSCO rises on report activist investor Barington Capital Group has built a stake By Investing.com

Victoria's Secret shares are up over 3% premarket following a Wall Street Journal report that Barington Capital Group has acquired a stake exceeding 1% and intends to increase its position. Barington believes Victoria's Secret has underperformed since its separation from Bath & Body Works, and plans to advocate for a board overhaul, a renewed focus on the core bra business, and a potential reevaluation of the beauty segment; the firm also intends to push for the repeal of the recently adopted poison pill, viewing it as counterproductive.

Analysis

Victoria’s Secret (VSCO) shares experienced a premarket increase of over 3% following reports of activist investor Barington Capital Group acquiring a stake exceeding 1%, with intentions to further augment this position. Barington's engagement stems from a belief that VSCO has significantly underperformed since its 2021 separation from Bath & Body Works, evidenced by a market capitalization decline from over $6.5 billion to approximately $1.5 billion. The activist firm intends to advocate for substantial changes, including a comprehensive board overhaul, a strategic refocus on the core bra business, and a re-evaluation of the beauty segment, which Barington estimates could be valued at the company's entire current market capitalization. Barington also critiques the current leadership's experience and strategic direction and plans to push for the repeal of Victoria's Secret's recently implemented poison pill, a measure adopted amidst pressure from another major shareholder, Brett Blundy. While Victoria's Secret has stated it awaits direct communication from Barington, it has expressed confidence in its current strategy under CEO Hillary Super. This activist intervention introduces a catalyst for potential strategic redirection and asset re-evaluation at VSCO, signaling a period of heightened scrutiny and potential change for the retailer.

Key Decisions for Investors

• Consider the potential for increased stock volatility and event-driven trading opportunities as Barington's activist campaign unfolds and interacts with existing shareholder pressures.
• Monitor developments regarding Barington's proposals for board changes and strategic shifts, especially concerning the core lingerie operations and the valuation of the beauty segment, as these could significantly impact future performance and shareholder value.
• Evaluate the risk of a prolonged proxy contest or management resistance, given the existing poison pill and stated confidence in the current strategy, which may delay or dilute the impact of activist demands on the company's turnaround efforts.